题名 | Preclinical Efficacy of Bevacizumab with CRLX101, an Investigational Nanoparticle–Drug Conjugate, in Treatment of Metastatic Triple-Negative Breast Cancer |
链接 | http://cancerres.aacrjournals.org/content/76/15/4493.short |
欢迎光临 科研速递论坛 (http://expaper.cn/) | Powered by Discuz! X2.5 |